We are live on ! Find out more
GILD icon

Gilead Sciences
GILD

1,575 hedge funds and large institutions have $73.2B invested in Gilead Sciences in 2017 Q4 according to their latest regulatory filings, with 202 funds opening new positions, 535 increasing their positions, 691 reducing their positions, and 116 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% more first-time investments, than exits

New positions opened: 202 | Existing positions closed: 116

5% more funds holding

Funds holding: 1,504 → 1,575 (+71)

1.25% more ownership

Funds ownership: 76.99% → 78.25% (+1.3%)

10% less capital invested

Capital invested by funds: $81.5B → $73.2B (-$8.37B)

23% less repeat investments, than reductions

Existing positions increased: 535 | Existing positions reduced: 691

40% less call options, than puts

Call options by funds: $1.57B | Put options by funds: $2.63B

46% less funds holding in top 10

Funds holding in top 10: 96 → 52 (-44)

Holders
1,575
Holders Change
+71
Holders Change %
+4.72%
% of All Funds
35.71%
Holding in Top 10
52
Holding in Top 10 Change
-44
Holding in Top 10 Change %
-45.83%
% of All Funds
1.18%
New
202
Increased
535
Reduced
691
Closed
116
Calls
$1.57B
Puts
$2.63B
Net Calls
-$1.06B
Net Calls Change
-$328M

Top Buyers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
+$794M
2
Capital World Investors
Capital World Investors
California
+$529M
3
Dodge & Cox
Dodge & Cox
California
+$418M
4
Sanders Capital
Sanders Capital
Florida
+$382M
5
CGI
CI Global Investments
California
+$275M

Top Sellers

Rank Fund Capital Flow
1
CWG
C WorldWide Group
Denmark
-$300M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$273M
3
Renaissance Technologies
Renaissance Technologies
New York
-$202M
4
Boston Partners
Boston Partners
Massachusetts
-$201M
5
Bank of America
Bank of America
North Carolina
-$194M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCFCSB
1376
Cape Cod Five Cents Savings Bank
Massachusetts
$233K +$9.87K +130 +4%
TPWA
1377
TRUE Private Wealth Advisors
Oregon
$233K +$247K +3,255 New
HCM
1378
Hollencrest Capital Management
California
$231K -$440K -5,800 -64%
TBA
1379
Tower Bridge Advisors
Pennsylvania
$231K -$4.56K -60 -2%
WA
1380
WBH Advisory
Maryland
$230K -$12.3K -162 -5%
RFM
1381
Royal Fund Management
Florida
$229K +$243K +3,206 New
DI
1382
Diligent Investors
California
$224K -$4.56K -60 -2%
GAG
1383
GM Advisory Group
New York
$221K -$2.58K -34 -1%
TCB
1384
Texas Capital Bancshares
Texas
$221K – – –
BFM
1385
Boothbay Fund Management
New York
$221K +$234K +3,079 New
OPPM
1386
Opus Point Partners Management
New York
$220K -$257K -3,387 -52%
FHC
1387
First Heartland Consultants
Missouri
$218K -$446K -5,878 -66%
KC
1388
Kingfisher Capital
North Carolina
$218K -$2.2K -29 -0.9%
AR
1389
Advisory Research
Illinois
$217K +$22.4K +295 +11%
CGA
1390
Crescent Grove Advisors
Illinois
$216K – – –
ACM
1391
Adalta Capital Management
New York
$215K – – –
RCM
1392
RB Capital Management
Nevada
$213K -$8.51K -112 -4%
TIA
1393
Tiemann Investment Advisors
California
$212K – – –
NFG
1394
Nations Financial Group
Iowa
$211K -$7.59K -100 -3%
ASA
1395
Armstrong Shaw Associates
Connecticut
$211K – – –
AW
1396
ACG Wealth
Georgia
$210K -$2.51K -33 -1%
WB
1397
Webster Bank
Connecticut
$210K +$116K +1,525 +109%
WAP
1398
Wealthcare Advisory Partners
Pennsylvania
$209K +$97.5K +1,284 +78%
CIC
1399
Cornercap Investment Counsel
Georgia
$208K -$4.25M -55,959 -95%
RT
1400
Rockland Trust
Massachusetts
$206K -$15.2K -200 -6%
54 55
56
57 58

GILD Hedge Fund Activity: Q4 2017 in Review

1,575 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q4 2017, worth a combined $73.2B — down 10% from $81.5B a quarter earlier.

Buyers outnumbered sellers: 202 funds opened new GILD positions and 116 closed out — a net gain of 86 holders — while 535 added to existing stakes and 691 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $794M. The largest seller was C WorldWide Group, cutting an estimated $300M.

  • 1,575 institutional investors held Gilead Sciences (GILD) as of Q4 2017, up from 1,504 in Q3 2017.
  • Funds reported $73.2B of Gilead Sciences stock for Q4 2017, down 10% quarter-over-quarter.
  • 202 funds opened new Gilead Sciences positions in Q4 2017 and 116 closed out, a net change of +86 holders.
  • The largest Gilead Sciences buyer in Q4 2017 was Capital Research Global Investors, an estimated $794M added.
  • The largest Gilead Sciences seller in Q4 2017 was C WorldWide Group, an estimated $300M sold.

Based on aggregated 13F filings for Q4 2017.